Results
eNauka >
Results >
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study
Title  : | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study | Authors: | Bergh, Florian Then; Singer, BA; Drulović, Jelena S.  ; Bidollari, I.; Chen, Hailu; Englishby, R.; Hanna, Jerome; Kandinov, Boris; Lopez-Bresnahan, Maria; Leigh-Pemberton, Richard; |
Issue Date: | 2019 | Publication: | Multiple sclerosis journal (35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS 2019), Sep 11-13, 2019, Stockholm, Sweden) | ISSN: | 1352-4585 Multiple Sclerosis Search Idenfier |
Publisher: | London : SAGE Publications | Type: | Conference Paper | Collation: | vol. 25 br. Suppl 2 str. 861-862 | WoS-ID: | 000485303103349 | URI: | https://enauka.gov.rs/handle/123456789/827905 | URL: | https://journals.sagepub.com/doi/full/10.1177/1352458519872904 | Project: | Biogen/Alkermes Biogen (Cambridge, MA, USA) Alkermes (Waltham, MA, USA) Biogen |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.